BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36858504)

  • 1. [Pharma challenges to adoption of microphysiological system in drug research and development, especially safety assessment].
    Naraoka H
    Nihon Yakurigaku Zasshi; 2023; 158(2):187-192. PubMed ID: 36858504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Current Status and Use of Microphysiological Systems by the Pharmaceutical Industry: The International Consortium for Innovation and Quality Microphysiological Systems Affiliate Survey and Commentary.
    Baker TK; Van Vleet TR; Mahalingaiah PK; Grandhi TSP; Evers R; Ekert J; Gosset JR; Chacko SA; Kopec AK
    Drug Metab Dispos; 2024 Feb; 52(3):198-209. PubMed ID: 38123948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development.
    Marx U; Akabane T; Andersson TB; Baker E; Beilmann M; Beken S; Brendler-Schwaab S; Cirit M; David R; Dehne EM; Durieux I; Ewart L; Fitzpatrick SC; Frey O; Fuchs F; Griffith LG; Hamilton GA; Hartung T; Hoeng J; Hogberg H; Hughes DJ; Ingber DE; Iskandar A; Kanamori T; Kojima H; Kuehnl J; Leist M; Li B; Loskill P; Mendrick DL; Neumann T; Pallocca G; Rusyn I; Smirnova L; Steger-Hartmann T; Tagle DA; Tonevitsky A; Tsyb S; Trapecar M; Van de Water B; Van den Eijnden-van Raaij J; Vulto P; Watanabe K; Wolf A; Zhou X; Roth A
    ALTEX; 2020; 37(3):365-394. PubMed ID: 32113184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of Microphysiological Systems (MPSs) Based on Microfluidic Technology for Drug Discovery in Japan].
    Kimura H
    Yakugaku Zasshi; 2023; 143(1):39-44. PubMed ID: 36596538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate).
    Baran SW; Brown PC; Baudy AR; Fitzpatrick SC; Frantz C; Fullerton A; Gan J; Hardwick RN; Hillgren KM; Kopec AK; Liras JL; Mendrick DL; Nagao R; Proctor WR; Ramsden D; Ribeiro AJS; Stresser D; Sung KE; Sura R; Tetsuka K; Tomlinson L; Van Vleet T; Wagoner MP; Wang Q; Arslan SY; Yoder G; Ekert JE
    ALTEX; 2022; 39(2):297–314. PubMed ID: 35064273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microphysiological systems in early stage drug development: Perspectives on current applications and future impact.
    Kopec AK; Yokokawa R; Khan N; Horii I; Finley JE; Bono CP; Donovan C; Roy J; Harney J; Burdick AD; Jessen B; Lu S; Collinge M; Sadeghian RB; Derzi M; Tomlinson L; Burkhardt JE
    J Toxicol Sci; 2021; 46(3):99-114. PubMed ID: 33642521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development.
    Hargrove-Grimes P; Low LA; Tagle DA
    Cells Tissues Organs; 2022; 211(3):269-281. PubMed ID: 34380142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toward Regulatory Acceptance of MPS-Cardiac Safety Assessment as an Example].
    Yamazaki D
    Yakugaku Zasshi; 2023; 143(1):55-63. PubMed ID: 36596540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pumped and pumpless microphysiological systems to study (nano)therapeutics.
    Lee EJ; Krassin ZL; Abaci HE; Mahler GJ; Esch MB
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1911. PubMed ID: 37464464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National reflection on organs-on-chip for drug development: New regulatory challenges.
    Teixeira SG; Houeto P; Gattacceca F; Petitcollot N; Debruyne D; Guerbet M; Guillemain J; Fabre I; Louin G; Salomon V
    Toxicol Lett; 2023 Oct; 388():1-12. PubMed ID: 37776962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From animal testing to
    Reyes DR; Esch MB; Ewart L; Nasiri R; Herland A; Sung K; Piergiovanni M; Lucchesi C; Shoemaker JT; Vukasinovic J; Nakae H; Hickman J; Pant K; Taylor A; Heinz N; Ashammakhi N
    Lab Chip; 2024 Feb; 24(5):1076-1087. PubMed ID: 38372151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standalone cell culture microfluidic device-based microphysiological system for automated cell observation and application in nephrotoxicity tests.
    Kimura H; Nakamura H; Goto T; Uchida W; Uozumi T; Nishizawa D; Shinha K; Sakagami J; Doi K
    Lab Chip; 2024 Jan; 24(3):408-421. PubMed ID: 38131210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New horizons of microphysiological systems: India forging its path in human-relevant research.
    Parvatam S; Mahadik K; Banerjee A; Patil K; Radha V; Rao M
    Biol Open; 2023 Apr; 12(4):. PubMed ID: 37070566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-industrial applications of organotypic models.
    Kopanska KS; Rimann M
    ALTEX; 2022; 39(1):155-158. PubMed ID: 35034134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmaceutical industry perspective on microphysiological kidney systems for evaluation of safety for new therapies.
    Phillips JA; Grandhi TSP; Davis M; Gautier JC; Hariparsad N; Keller D; Sura R; Van Vleet TR
    Lab Chip; 2020 Feb; 20(3):468-476. PubMed ID: 31989145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems.
    Hughes DJ; Kostrzewski T; Sceats EL
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1593-1604. PubMed ID: 28504617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ-On-A-Chip: An Emerging Research Platform.
    R N; Aggarwal A; Sravani AB; Mallya P; Lewis S
    Organogenesis; 2023 Dec; 19(1):2278236. PubMed ID: 37965897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organs-on-a-Chip.
    Low LA; Sutherland M; Lumelsky N; Selimovic S; Lundberg MS; Tagle DA
    Adv Exp Med Biol; 2020; 1230():27-42. PubMed ID: 32285363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective.
    Ainslie GR; Davis M; Ewart L; Lieberman LA; Rowlands DJ; Thorley AJ; Yoder G; Ryan AM
    Lab Chip; 2019 Sep; 19(19):3152-3161. PubMed ID: 31469131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.